Kirkland & Ellis is acting as U.S. legal counsel to a buyer group – Dream Investment Holdings and its subsidiary, Dream Merger Sub Limited – on its agreement to purchase iDreamSky Technology, China’s leading mobile game distributor.

Led by Michael Xiangyu Chen, iDreamSky’s CEO and chairman of the board, the consortium will acquire the NASDAQ-listed tech firm for a cash consideration worth $3.50 per Class A and Class B ordinary share or $14 per American depositary share, which values the company at about $620 million.

K&E’s team is headed by Hong Kong corporate partners David Zhang, Jesse Sheley and Amie Tang.  Walkers is serving as the consortium’s adviser in matters pertaining to Cayman Islands law. 

Shearman & Sterling is advising iDreamSky’s special committee, composed of independent directors of the company’s board, with a team led by Hong Kong partner Paul Strecker. He is being assisted by Menlo Park-based partners Larry Crouch and Richard Hsu.

Maples and Calder is advising the special committee on Cayman Islands law. Hogan Lovells is representing Duff & Phelps, the committee’s financial advisor.

The deal, which is expected to be completed in the second quarter of 2016, is subject to various closing conditions and shareholder approval.

Related Articles

海问、凯易助力港交所18A企业第一宗反向收购案例(ZH/EN)

近日,港交所18A上市企业嘉和生物宣布与亿腾医药达成合并协议,合并后企业将更名为亿腾嘉和医药集团有限公司。海问律师事务所担任嘉和生物的法律顾问,凯易国际律师事务所则代表亿腾医药参与交易。

礼德、富而德、凯易助力复宏汉霖54亿港元私有化交易(ZH/EN)

上海复星医药日前宣布,其控股子公司复星新药拟吸收合并及私有化港交所上市公司复宏汉霖。礼德律师事务所为复星提供服务;富而德律师事务所代表复宏汉霖参与交易;凯易国际律师事务所则为财务顾问中金公司提供法律意见。

中概股接连迎来两宗重大交易,汉坤、凯易等扮演领衔角色(ZH/EN)

过去两周,来自中国湖北武汉的超跑电动车制造商路特斯,以及来自湖南长沙的互联网券商微牛,先后通过SPAC合并交易实现在美国纳斯达克上市。